Strisciuglio P, Parenti G, Giudice C, Lijoi S, Hoogeveen A T, d'Azzo A
Department of Pediatrics, 2nd Faculty of Medicine, University of Naples, Italy.
Hum Genet. 1988 Nov;80(3):304-6. doi: 10.1007/BF01790104.
The biochemical defect underlying the late infantile form of galactosialidosis has been investigated in fibroblasts from two patients presenting with this phenotype. Immunoprecipitation experiments demonstrated that a reduced amount of 32-kd "protective" protein and a normal amount of its precursor are present in late infantile galactosialidosis fibroblasts, while neither of the two polypeptides are detectable in early infantile and juvenile/adult fibroblasts. Leupeptin treatment led to a slight increase in the amount of 54-kd and 32-kd polypeptides in both late-infantile galactosialidosis cell lines. Uptake studies in one of the two cell lines confirmed the hypothesis that a block in the maturation of the protective protein is responsible for the late infantile type of galactosialidosis. This mutation seems to be a distinct finding in all patients affected by this form of the disease.
针对两名呈现晚发性婴儿型半乳糖唾液酸贮积症表型患者的成纤维细胞,对该疾病潜在的生化缺陷进行了研究。免疫沉淀实验表明,在晚发性婴儿型半乳糖唾液酸贮积症的成纤维细胞中,32-kd“保护”蛋白的量减少,而其前体的量正常,而在早发性婴儿型和青少年/成人成纤维细胞中均未检测到这两种多肽。亮肽素处理导致两个晚发性婴儿型半乳糖唾液酸贮积症细胞系中54-kd和32-kd多肽的量略有增加。在两个细胞系之一中进行的摄取研究证实了以下假设:保护蛋白成熟过程中的阻断是晚发性婴儿型半乳糖唾液酸贮积症的病因。这种突变似乎是所有受这种疾病形式影响的患者中的一个独特发现。